Antiproliferative Effect of Natural Beta Interferon on Fresh Tumor Cells Analyzed in a Clonogenic Assay

Abstract
Natural beta interferon (βIFN), derived from diploid fibroblasts, has been evaluated for its antiproliferative activity using a panel of twelve different histologic types of fresh human tumor cells. Thirty-nine percent (9/23) of the tumors showed a 70% or greater decrease in colony formation following exposure to 500 international reference units per ml of natural βIFN, a concentration which is in the clinically achievable range. Interesting, is that leiomyosarcoma, a tumor relatively resistant to conventional chemotherapy, was uniformly sensitive (3/3) to natural βIFN. Indeed, the antiproliferative activity of βIFN was consistently superior (in 19/20 comparative assays) to the other conventional chemotherapeutic drugs evaluated for leiomyosarcomas. This study, which suggests that natural βIFN exhibits significant antiproliferative activity on a variety of fresh human tumor cells, may be useful in orienting clinical trials with natural βIFN (still in limited supply because of its unique physicochemical nature) to the more susceptible human malignancies.